The demonstration of increased CRP, specifically among infants with chorioamnionitis plus funisitis, underscores the importance of cataloging surrogate markers of perinatal inflammation that could signal the need for enhanced surveillance for potential adverse outcomes. This evidence concerns the gene CRP and chorioamnionitis.